Search research articles
Contact Us
Filters
Showing results (11-20 of 79) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
May 29, 2020
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Xinrui Yuan, Hong Bu, Jinpei Zhou, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
May 18, 2010
The application of an aryl hydrazine linker prevents beta-elimination side products in the SPPS of C-terminal cysteine peptides
Shuaijian Ni, Huibin Zhang, Wenlong Huang, et al.
Bioorganic & Medicinal Chemistry
|
March 3, 2019
Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors
Xinrui Yuan, Hanshu Wu, Hong Bu, et al.
Bioorganic & Medicinal Chemistry
|
March 13, 2019
Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors
Xiaojun Yang, Shi Cai, Xueting Liu, et al.
Bioorganic Chemistry
|
December 2, 2019
Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors
Shi Cai, Xiaojun Yang, Pan Chen, et al.
Chemmedchem
|
May 30, 2018
Design, Synthesis, and in vitro Biological Evaluation of 3,5-Dimethylisoxazole Derivatives as BRD4 Inhibitors
Xiangyang Li, Jian Zhang, Leilei Zhao, et al.
Bioorganic & Medicinal Chemistry
|
April 16, 2021
Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family
Lincheng Fang, Zhaoxue Hu, Yifei Yang, et al.
Bioorganic Chemistry
|
June 20, 2020
Design, synthesis and biological evaluation of novel chroman derivatives as non-selective acetyl-CoA carboxylase inhibitors
Qiangqiang Wei, Liankuo Mei, Pan Chen, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 19, 2011
Qualitative and quantitative studies on impurities in G004, a potential hypoglycaemic agent, using liquid chromatography, nuclear magnetic resonance and mass spectrometry
Wenyuan Liu, Ainan Zhou, Feng Feng, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2019
Pharmacokinetics-Driven Optimization of 7-Methylimidazo[1,5-<i>a</i>]pyrazin-8(7H)-one as Novel BRD4 Inhibitors
Yifei Yang, Pan Chen, Leilei Zhao, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 79) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
May 29, 2020
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Xinrui Yuan, Hong Bu, Jinpei Zhou, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
May 18, 2010
The application of an aryl hydrazine linker prevents beta-elimination side products in the SPPS of C-terminal cysteine peptides
Shuaijian Ni, Huibin Zhang, Wenlong Huang, et al.
Bioorganic & Medicinal Chemistry
|
March 3, 2019
Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors
Xinrui Yuan, Hanshu Wu, Hong Bu, et al.
Bioorganic & Medicinal Chemistry
|
March 13, 2019
Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors
Xiaojun Yang, Shi Cai, Xueting Liu, et al.
Bioorganic Chemistry
|
December 2, 2019
Design, synthesis and biological evaluation of bicyclic carboxylic acid derivatives as IDO1 inhibitors
Shi Cai, Xiaojun Yang, Pan Chen, et al.
Chemmedchem
|
May 30, 2018
Design, Synthesis, and in vitro Biological Evaluation of 3,5-Dimethylisoxazole Derivatives as BRD4 Inhibitors
Xiangyang Li, Jian Zhang, Leilei Zhao, et al.
Bioorganic & Medicinal Chemistry
|
April 16, 2021
Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family
Lincheng Fang, Zhaoxue Hu, Yifei Yang, et al.
Bioorganic Chemistry
|
June 20, 2020
Design, synthesis and biological evaluation of novel chroman derivatives as non-selective acetyl-CoA carboxylase inhibitors
Qiangqiang Wei, Liankuo Mei, Pan Chen, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 19, 2011
Qualitative and quantitative studies on impurities in G004, a potential hypoglycaemic agent, using liquid chromatography, nuclear magnetic resonance and mass spectrometry
Wenyuan Liu, Ainan Zhou, Feng Feng, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2019
Pharmacokinetics-Driven Optimization of 7-Methylimidazo[1,5-<i>a</i>]pyrazin-8(7H)-one as Novel BRD4 Inhibitors
Yifei Yang, Pan Chen, Leilei Zhao, et al.
Page
of 8